{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:33:32Z","timestamp":1771493612683,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,1,7]],"date-time":"2014-01-07T00:00:00Z","timestamp":1389052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropathology"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:p>Temozolomide (<jats:styled-content style=\"fixed-case\">TMZ<\/jats:styled-content>) is an oral alkylating agent which is widely used in the treatment of glioblastoma (<jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content>) and is composed of astrocytic and\/or oligodendroglial tumors, and the evaluation of <jats:styled-content style=\"fixed-case\">O<jats:sup>6<\/jats:sup><\/jats:styled-content>\u2010methylguanine <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> methyltransferase (<jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content>) expression is important to predict the response to <jats:styled-content style=\"fixed-case\">TMZ<\/jats:styled-content> therapy. In this study, we conducted immunohistochemical analysis of 117 cases of Japanese <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> including 19 cases of <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> with oligodendroglioma component (<jats:styled-content style=\"fixed-case\">GBMO<\/jats:styled-content>), using a scoring system for quantitative evaluation of staining intensity and proportion of <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content>, and performed survival analysis of these patients. Immunohistochemically, 55 cases (47%) were positive for <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> with various intensities and proportions (total score (<jats:styled-content style=\"fixed-case\">TS<\/jats:styled-content>)\u2009\u2265\u20092), while 62 cases (53%) were negative (<jats:styled-content style=\"fixed-case\">TS<\/jats:styled-content>\u2009=\u20090). The distribution of <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> expression pattern was not affected by any clinicopathological parameters such as the histological subtype (<jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> vs. <jats:styled-content style=\"fixed-case\">GBMO<\/jats:styled-content>), age and gender. The survival analysis of these patients revealed that the minimal expression of <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">TS<\/jats:styled-content>\u2009\u2265\u20092) was a significant unfavorable prognostic factor (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) as well as resectability (<jats:italic>P<\/jats:italic>\u2009=\u20090.004). Moreover, multivariate analysis showed that minimal <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> expression in <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content> was the most potent independent predictor for progression free survival (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and also overall patient survival (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). This is the first report employing the scoring system for both staining intensity and proportion to evaluate immunohistochemical <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> expression in <jats:styled-content style=\"fixed-case\">GBM<\/jats:styled-content>. In addition, our results emphases the clinicopathological values of the immunohistochemical approach for <jats:styled-content style=\"fixed-case\">MGMT<\/jats:styled-content> expression in glioma patients as a routine laboratory examination.<\/jats:p>","DOI":"10.1111\/neup.12091","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T03:26:53Z","timestamp":1389151613000},"page":"268-276","source":"Crossref","is-referenced-by-count":20,"title":["Immunohistochemical evaluation of <scp>O<sup>6<\/sup><\/scp>\u2010methylguanine <scp>DNA<\/scp> methyltransferase (<scp>MGMT<\/scp>) expression in 117 cases of glioblastoma"],"prefix":"10.1111","volume":"34","author":[{"given":"Masaya","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Department of Cancer Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[{"name":"Department of Translational Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"},{"name":"Laboratory of Oncology Hokuto Hospital  Obihiro Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Terasaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamio","family":"Ito","sequence":"additional","affiliation":[{"name":"Nakamura Memorial Hospital  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuta","family":"Kamoshima","sequence":"additional","affiliation":[{"name":"Sapporo Azabu Neurosurgical Hospital  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Kashiwaba Neurosurgical Hospital  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Kashiwaba Neurosurgical Hospital  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Katoh","sequence":"additional","affiliation":[{"name":"Hokkaido Neurosurgical Memorial Hospital  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Keiwakai Ebetsu Hospital  Ebetsu Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Mohri","sequence":"additional","affiliation":[{"name":"Laboratory of Oncology Hokuto Hospital  Obihiro Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishie","family":"Tanino","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"},{"name":"Department of Translational Pathology Hokkaido University Graduate School of Medicine  Sapporo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,1,7]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis DN","year":"2007"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20069"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0562-9"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jnen.0000235118.75182.94"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2004.01887.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s004010000258","article-title":"Molecular genetic alterations in glioblastomas with oligodendroglial component","volume":"101","author":"Kraus JA","year":"2001","journal-title":"Acta Neuropathol (Berl)"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-9815-6"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.1497"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041669"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc1155"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-05-0128"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0715"},{"key":"e_1_2_6_15_1","first-page":"421","article-title":"Thresholds of O6\u2010alkylguanine\u2010DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3\u2010bis(2\u2010chloroethyl)\u20101\u2010nitrosourea or temozolomide","volume":"7","author":"Kokkinakis DM","year":"2001","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043331"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2009-001"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70025-7"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011093431901"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2801"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.6650"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0384"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-0031-1"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27441"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318267b061"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos308"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1227\/01.NEU.0000357325.90347.A1"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2008.00153.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e31802fac2f"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-35"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1179\/016164103101201445"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.4807"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.99.3.0467"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(96)00211-0"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.1983"},{"key":"e_1_2_6_37_1","first-page":"469","article-title":"Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas","volume":"33","author":"Yachi K","year":"2008","journal-title":"Int J Oncol"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0065-6"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.12.3851"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.144"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21153"},{"key":"e_1_2_6_42_1","first-page":"21","article-title":"Chemotherapy\u2010induced bystander effect in response to several chloroethylnitrosoureas: an origin independent of DNA damage?","volume":"28","author":"Merle P","year":"2008","journal-title":"Anticancer Res"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2009.06.003"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.12.005"}],"container-title":["Neuropathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fneup.12091","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/neup.12091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:18:46Z","timestamp":1696274326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/neup.12091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/neup.12091"],"URL":"https:\/\/doi.org\/10.1111\/neup.12091","archive":["Portico"],"relation":{},"ISSN":["0919-6544","1440-1789"],"issn-type":[{"value":"0919-6544","type":"print"},{"value":"1440-1789","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,7]]}}}